Shattuck Labs (STTK) Interest Coverage Ratio (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Interest Coverage Ratio of 0.13 for Q4 2025, up 38.98% year-over-year from 0.09 in Q4 2024, and up 99.53% quarter-over-quarter from 26.79 in Q3 2025.
Shattuck Labs (STTK) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Interest Coverage Ratio for 7 consecutive years, with 0.13 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 38.98% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 263.32 (changed N/A YoY), while the FY2025 annual figure was 0.48, up 42.7% from the prior year.
- Interest Coverage Ratio rose to 0.13 in Q4 2025 per STTK's latest filing, from 26.79 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 131.38 in Q4 2022 and bottomed at 285.98 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 29.8 across 5 years, with a median of 3.48 in 2022.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 42998.49% — and 2023, when it slumped 7203.38%.
- Shattuck Labs' Interest Coverage Ratio stood at 0.3 in 2021, then soared by 42998.49% to 131.38 in 2022, then plunged by 100.19% to 0.25 in 2023, then grew by 17.21% to 0.21 in 2024, then surged by 38.98% to 0.13 in 2025.
- Business Quant data shows STTK's Interest Coverage Ratio at 0.13 in Q4 2025, 26.79 in Q3 2025, and 130.32 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | -1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.08 |
| Dec 31, 2025 | -0.13 |
| Sep 30, 2025 | -26.79 |
| Jun 30, 2025 | -130.32 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -22.40 |
| Jun 30, 2024 | -17.66 |
| Mar 31, 2024 | -1.62 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -285.98 |
| Jun 30, 2023 | -75.82 |
| Mar 31, 2023 | -108.31 |
| Dec 31, 2022 | 131.38 |
| Sep 30, 2022 | -3.92 |
| Jun 30, 2022 | -18.60 |
| Mar 31, 2022 | -3.48 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | -0.91 |
| Jun 30, 2021 | -0.94 |
| Mar 31, 2021 | -0.47 |